Thomas R Sellers1, Adham Abdelfattah2, Mark A Frankle3. 1. Department of Orthopaedic Surgery, University of South Florida, Tampa, FL, USA. 2. South Texas Bone and Joint Institute, San Antonio, TX, USA. 3. Shoulder and Elbow Service, Florida Orthopaedic Institute, 13020 N Telecom Pkwy, Tampa, FL, 33637, USA. mfrankle@floridaortho.com.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to discuss the indications for reverse shoulder arthroplasty (RSA) in the treatment of massive rotator cuff tear (MCT), review the reported outcomes in the literature, and outline our approach and surgical technique for treating these patients. RECENT FINDINGS: While RSA remains a successful and well-accepted treatment for cuff tear arthropathy (CTA), management of MCT in the absence of arthritis is controversial. In this particular setting, patients best suited for RSA are elderly, lower-demand individuals with chronic, irreparable MCT, and pseudoparalysis. Age < 60, better pre-operative function and upper extremity neurologic dysfunction are potential risk factors for poor outcome with RSA in this population. Long-term follow-up studies of RSA for CTA and MCT show good functional outcomes and implant survival > 90% at 10 years. Treatment of MCT must be individualized for each patient. When patient selection is optimized, RSA is a reliable means of relieving pain and improving function with excellent success. Further investigation is necessary to better define its indications and assess the role of alternative, joint-salvaging procedures.
PURPOSE OF REVIEW: The purpose of this review is to discuss the indications for reverse shoulder arthroplasty (RSA) in the treatment of massive rotator cuff tear (MCT), review the reported outcomes in the literature, and outline our approach and surgical technique for treating these patients. RECENT FINDINGS: While RSA remains a successful and well-accepted treatment for cuff tear arthropathy (CTA), management of MCT in the absence of arthritis is controversial. In this particular setting, patients best suited for RSA are elderly, lower-demand individuals with chronic, irreparable MCT, and pseudoparalysis. Age < 60, better pre-operative function and upper extremity neurologic dysfunction are potential risk factors for poor outcome with RSA in this population. Long-term follow-up studies of RSA for CTA and MCT show good functional outcomes and implant survival > 90% at 10 years. Treatment of MCT must be individualized for each patient. When patient selection is optimized, RSA is a reliable means of relieving pain and improving function with excellent success. Further investigation is necessary to better define its indications and assess the role of alternative, joint-salvaging procedures.
Authors: Pascal Boileau; Barbara Melis; David Duperron; Grégory Moineau; Adam P Rumian; Yung Han Journal: J Shoulder Elbow Surg Date: 2013-05-22 Impact factor: 3.019
Authors: Patrick Henry; David Wasserstein; Sam Park; Tim Dwyer; Jaskarndip Chahal; Gerard Slobogean; Emil Schemitsch Journal: Arthroscopy Date: 2015-09-11 Impact factor: 4.772
Authors: Brandon J Erickson; Daphne Ling; Alexandra Wong; Joshua S Dines; David M Dines; Lawrence V Gulotta Journal: Orthop J Sports Med Date: 2020-08-25